Emisjon 2023 - 145M aksjer, Kurs 0,85
Tenker det kan være greit med en egen tråd om emisjonen:
https://www.globenewswire.com/news-release/2023/05/24/2675443/0/en/IDEX-Biometrics-ASA-Contemplated-Private-Placement-24-May-2023.html
Oslo, 24 May 2023.
IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint identification and authentications solutions, has retained ABG Sundal Collier ASA and Arctic Securities AS as Joint Bookrunners (the "Managers") to advise on and effect a private placement (the "Private Placement") of new shares in the Company (the "Offer Shares") to raise gross proceeds of approximately NOK 100-150 million.
The net proceeds from the Private Placement will be used to accelerate the Company’s product commercialization and for working capital and general corporate purposes.
The subscription price per Offer Share (the "Offer Price") and the number of Offer Shares to be issued in the Private Placement will be determined by the board of directors of the Company (the "Board") following an accelerated bookbuilding process. The bookbuilding period commences today at 16:30 CEST and ends at 08:00 CEST on 25 May 2023. The bookbuilding period may, at the discretion of the Company and the Managers, close earlier or later and may be cancelled at any time and, consequently, the Company may refrain from completing the Private Placement.
The Company will announce the final number of Offer Shares placed and the final Offer Price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023.
The Private Placement will be directed towards Norwegian and international investors, in each case subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000, provided that the Company may, at its sole discretion, allocate an amount below EUR 100,000 to the extent applicable exemptions from relevant prospectus and registration requirements pursuant to applicable regulations, including Regulation (EU) 2017/1129 (the EU Prospectus Regulation) and ancillary regulations, are available.
The Private Placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 Offer Shares (representing approximately 10% of the outstanding shares in the Company) ("Tranche 1" and the "Tranche 1 Offer Shares"). Tranche 2 will consist of up to the number of Offer Shares that, together with the Tranche 1 Offer Shares, is necessary in order to raise gross proceeds of NOK 100-150 million ("Tranche 2" and the "Tranche 2 Offer Shares"). Allocations of Offer Shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. Completion of Tranche 2 will be subject to approval by an extraordinary general meeting of the Company expected to be held on or about 16 June 2023 (the "EGM").
Allocation of Offer Shares will be determined by the Board at its sole discretion, in consultation with the Managers, following the expiry of the bookbuilding period, however subject to approval by the EGM in respect of Tranche 2. Allocation will be based on criteria such as (but not limited to), existing ownership in the Company, timeliness of the application, price leadership, relative order size, sector knowledge, investment history, perceived investor quality and investment horizon. The Board may, at its sole discretion, reject and/or reduce any applications, and there is no guarantee that any applicant will be allocated Offer Shares. Notification of allocation and payment instructions are expected to be issued to the applicants on or about 25 May 2023 through a notification to be issued by the Managers.
Completion of Tranche 1 is subject to approval by the Board. Completion of Tranche 2 is subject to completion of Tranche 1 and (ii) the approval by the EGM. Further to this, completion of both Tranche 1 and Tranche 2 are subject to the Company resolving to consummate the Private Placement and allocate the Offer Shares. Completion of Tranche 1 will not be conditional upon or otherwise affected by the completion of Tranche 2, and the applicants' acquisition of Tranche 1 Offer Shares will remain final and binding and cannot be revoked, cancelled or terminated by the respective applicants if Tranche 2, for whatever reason, is not completed. Investors being allocated shares in the Private Placement undertake to vote in favour of Tranche 2 at the EGM.
Both Tranche 1 and Tranche 2 will be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement entered into between the Company, the Managers and certain existing shareholders (the "Share Lending Agreement"). The share loan in Tranche 1 will be settled with new shares in the Company to be resolved issued by the Board pursuant to an authorisation by the Company’s annual general meeting held on 23 May 2023 . The share loan in Tranche 2 will be settled with new shares in the Company expected to be issued following, and subject to, approval by the EGM. The new shares to be redelivered to the lenders under the Share Lending Agreement will, to the extent required, be delivered on a separate and non-tradable ISIN, pending publication by the Company of a listing prospectus approved by the Norwegian Financial Supervisory Authority.
Settlement of the Tranche 1 Offer Shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 Offer Shares is expected to take place on a delivery versus payment basis on or about 20 June 2023, subject to approval by the EGM.
The Company reserves the right, at any time and for any reason, to cancel, and/or modify the terms of, the Private Placement prior to delivery of the Tranche 1 Offer Shares. Neither the Company nor the Managers will be liable for any losses incurred by applicants if the Private Placement is cancelled, irrespective of the reason for such cancellation.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it will be in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the funding alternatives currently available to the Company. A private placement enables the Company to raise capital in an efficient manner, and the Private Placement is structured to ensure that a market-based subscription price is achieved. The Company is of the view that the discount in a rights issue would have to be quite significant, and that a rights issue would need to be guaranteed by a consortium of underwriters, which would entail an added cost for the Company. By structuring the equity raise as a private placement, the Company is expected to be in a position to raise capital at a better share price, at a lower cost and with significantly lower risk than in a rights issue.
The Company may, subject to completion of the Private Placement, approval from the EGM and certain other conditions, consider to carry out a subsequent repair offering of new shares at the Offer Price directed towards existing shareholders in the Company as of 24 May 2023 (as registered in the VPS on 26 May 2023), who were not allocated Offer Shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action.
https://www.globenewswire.com/news-release/2023/05/24/2675443/0/en/IDEX-Biometrics-ASA-Contemplated-Private-Placement-24-May-2023.html
Oslo, 24 May 2023.
IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint identification and authentications solutions, has retained ABG Sundal Collier ASA and Arctic Securities AS as Joint Bookrunners (the "Managers") to advise on and effect a private placement (the "Private Placement") of new shares in the Company (the "Offer Shares") to raise gross proceeds of approximately NOK 100-150 million.
The net proceeds from the Private Placement will be used to accelerate the Company’s product commercialization and for working capital and general corporate purposes.
The subscription price per Offer Share (the "Offer Price") and the number of Offer Shares to be issued in the Private Placement will be determined by the board of directors of the Company (the "Board") following an accelerated bookbuilding process. The bookbuilding period commences today at 16:30 CEST and ends at 08:00 CEST on 25 May 2023. The bookbuilding period may, at the discretion of the Company and the Managers, close earlier or later and may be cancelled at any time and, consequently, the Company may refrain from completing the Private Placement.
The Company will announce the final number of Offer Shares placed and the final Offer Price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023.
The Private Placement will be directed towards Norwegian and international investors, in each case subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000, provided that the Company may, at its sole discretion, allocate an amount below EUR 100,000 to the extent applicable exemptions from relevant prospectus and registration requirements pursuant to applicable regulations, including Regulation (EU) 2017/1129 (the EU Prospectus Regulation) and ancillary regulations, are available.
The Private Placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 Offer Shares (representing approximately 10% of the outstanding shares in the Company) ("Tranche 1" and the "Tranche 1 Offer Shares"). Tranche 2 will consist of up to the number of Offer Shares that, together with the Tranche 1 Offer Shares, is necessary in order to raise gross proceeds of NOK 100-150 million ("Tranche 2" and the "Tranche 2 Offer Shares"). Allocations of Offer Shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. Completion of Tranche 2 will be subject to approval by an extraordinary general meeting of the Company expected to be held on or about 16 June 2023 (the "EGM").
Allocation of Offer Shares will be determined by the Board at its sole discretion, in consultation with the Managers, following the expiry of the bookbuilding period, however subject to approval by the EGM in respect of Tranche 2. Allocation will be based on criteria such as (but not limited to), existing ownership in the Company, timeliness of the application, price leadership, relative order size, sector knowledge, investment history, perceived investor quality and investment horizon. The Board may, at its sole discretion, reject and/or reduce any applications, and there is no guarantee that any applicant will be allocated Offer Shares. Notification of allocation and payment instructions are expected to be issued to the applicants on or about 25 May 2023 through a notification to be issued by the Managers.
Completion of Tranche 1 is subject to approval by the Board. Completion of Tranche 2 is subject to completion of Tranche 1 and (ii) the approval by the EGM. Further to this, completion of both Tranche 1 and Tranche 2 are subject to the Company resolving to consummate the Private Placement and allocate the Offer Shares. Completion of Tranche 1 will not be conditional upon or otherwise affected by the completion of Tranche 2, and the applicants' acquisition of Tranche 1 Offer Shares will remain final and binding and cannot be revoked, cancelled or terminated by the respective applicants if Tranche 2, for whatever reason, is not completed. Investors being allocated shares in the Private Placement undertake to vote in favour of Tranche 2 at the EGM.
Both Tranche 1 and Tranche 2 will be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement entered into between the Company, the Managers and certain existing shareholders (the "Share Lending Agreement"). The share loan in Tranche 1 will be settled with new shares in the Company to be resolved issued by the Board pursuant to an authorisation by the Company’s annual general meeting held on 23 May 2023 . The share loan in Tranche 2 will be settled with new shares in the Company expected to be issued following, and subject to, approval by the EGM. The new shares to be redelivered to the lenders under the Share Lending Agreement will, to the extent required, be delivered on a separate and non-tradable ISIN, pending publication by the Company of a listing prospectus approved by the Norwegian Financial Supervisory Authority.
Settlement of the Tranche 1 Offer Shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 Offer Shares is expected to take place on a delivery versus payment basis on or about 20 June 2023, subject to approval by the EGM.
The Company reserves the right, at any time and for any reason, to cancel, and/or modify the terms of, the Private Placement prior to delivery of the Tranche 1 Offer Shares. Neither the Company nor the Managers will be liable for any losses incurred by applicants if the Private Placement is cancelled, irrespective of the reason for such cancellation.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it will be in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the funding alternatives currently available to the Company. A private placement enables the Company to raise capital in an efficient manner, and the Private Placement is structured to ensure that a market-based subscription price is achieved. The Company is of the view that the discount in a rights issue would have to be quite significant, and that a rights issue would need to be guaranteed by a consortium of underwriters, which would entail an added cost for the Company. By structuring the equity raise as a private placement, the Company is expected to be in a position to raise capital at a better share price, at a lower cost and with significantly lower risk than in a rights issue.
The Company may, subject to completion of the Private Placement, approval from the EGM and certain other conditions, consider to carry out a subsequent repair offering of new shares at the Offer Price directed towards existing shareholders in the Company as of 24 May 2023 (as registered in the VPS on 26 May 2023), who were not allocated Offer Shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action.
Redigert 25.05.2023 kl 06:58
Du må logge inn for å svare
-
«
- 1
- 2 »
Sente
24.05.2023 kl 17:37
6675
I henhold til generalforsamling kan de kun lage 116 millioner aksjer, og de har mål om 100-150 million NOK.
Da er det litt negativt ladet at de varsler 2 runder, med EGM for å godkjenne den andre.
Hvis emisjonskursen er 0,86 får de inn 100 millioner med 116M aksjer. Det kan se ut som Idex ikke tror de klarer denne kursen, med tanke på den slappe holdningen til de siste ukene med børsmeldinger og de planlegger EGM med runde to emisjon.
Jeg tipper emisjonen blir overtegnet og de henter inn 150 millioner kroner i to runder. Med 150 millioner har de råd til to kvartaler med dagens burn rate.
Da er det litt negativt ladet at de varsler 2 runder, med EGM for å godkjenne den andre.
Hvis emisjonskursen er 0,86 får de inn 100 millioner med 116M aksjer. Det kan se ut som Idex ikke tror de klarer denne kursen, med tanke på den slappe holdningen til de siste ukene med børsmeldinger og de planlegger EGM med runde to emisjon.
Jeg tipper emisjonen blir overtegnet og de henter inn 150 millioner kroner i to runder. Med 150 millioner har de råd til to kvartaler med dagens burn rate.
poki
24.05.2023 kl 18:31
6527
Den är redan tecknad av 😝 Larry G vänner kan jag tänka mig. Det få vi veta den 30/05
Redigert 24.05.2023 kl 18:33
Du må logge inn for å svare
ibyx
24.05.2023 kl 18:43
6485
Slik melder DN hendelsen. Litt artig vedheng om største eier der. Visste ikke det.
"Den britiske investoren Robert Keith er største eier i Idex, med 18 prosent av aksjene"
Det ligger gjerne litt i kortene at Spetalen ikke er så interessert i IDEX? :-)
Mon tro om Mr. Keith er med i emisjonen? Han vil vel ikke utvannes?
https://investor.dn.no/#!/Oversikt/Direkte/133571
"Den britiske investoren Robert Keith er største eier i Idex, med 18 prosent av aksjene"
Det ligger gjerne litt i kortene at Spetalen ikke er så interessert i IDEX? :-)
Mon tro om Mr. Keith er med i emisjonen? Han vil vel ikke utvannes?
https://investor.dn.no/#!/Oversikt/Direkte/133571
Redigert 24.05.2023 kl 18:43
Du må logge inn for å svare
Sente
24.05.2023 kl 19:34
6308
I følge Idex sin offisielle list, nei:
https://www.idexbiometrics.com/investors/share-information/shareholders-2/
I følge Årsrapporten:
as of November 18, 2022, that he, together with “related parties,” collectively held 135,145,579 Ordinary Shares, representing 12.1% of the total number of our outstanding Ordinary Shares as of that date.
https://www.idexbiometrics.com/investors/share-information/shareholders-2/
I følge Årsrapporten:
as of November 18, 2022, that he, together with “related parties,” collectively held 135,145,579 Ordinary Shares, representing 12.1% of the total number of our outstanding Ordinary Shares as of that date.
murpy
24.05.2023 kl 19:40
6265
Bare det å sitte i aksjen med den gjengen der, er helt uaktuelt for min del. Les litt historie folkens. Det er ingen som kommer ut med gevinst i denne uten at man dagtrader.
rosgun
24.05.2023 kl 19:51
6200
Dette var KJEMPE GOD MELDING.
Hvorfor?
Det er kun en formalitet nå, og de som har snakket ned aksjen bare bekrefter min mistanke om at finanseliten skal inn TIL GOD PRIS……det er alt.
Et perfekt innsidetrekk som både Sente , Ibux og i trader har bidratt med….. ingen vet hvem hvem er og det er helt tydelig at alle disse tre er rett på Idex…..
En rettet emisjon som spådd med Sundt as som vanlig og en utvanning på 10% gir eminkurs på ca 0,8….
Da er spenningen utløst og aksjen vil gå i været som jeg sa i juli-august. Tipper kurs15.8 til kr 3,50….
Her er det mange som vil gå inn for å sikre gode feriepenger.
Gratulerer til alle baissere, dere klarte det igjen😡😡😡
Hvorfor?
Det er kun en formalitet nå, og de som har snakket ned aksjen bare bekrefter min mistanke om at finanseliten skal inn TIL GOD PRIS……det er alt.
Et perfekt innsidetrekk som både Sente , Ibux og i trader har bidratt med….. ingen vet hvem hvem er og det er helt tydelig at alle disse tre er rett på Idex…..
En rettet emisjon som spådd med Sundt as som vanlig og en utvanning på 10% gir eminkurs på ca 0,8….
Da er spenningen utløst og aksjen vil gå i været som jeg sa i juli-august. Tipper kurs15.8 til kr 3,50….
Her er det mange som vil gå inn for å sikre gode feriepenger.
Gratulerer til alle baissere, dere klarte det igjen😡😡😡
elnomi
24.05.2023 kl 20:01
6142
Er det mulig?
Enda en emisjon i idex, hvordan er det mulig?
For et jallaselskap, kommer nok aldri til å til å levere lønnsom drift. Stay away!
Enda en emisjon i idex, hvordan er det mulig?
For et jallaselskap, kommer nok aldri til å til å levere lønnsom drift. Stay away!
Winter is Here
24.05.2023 kl 20:13
6092
Fredag 19. mai ble Idex Biometrics tatt inn i Investtechs «hold-deg-unna-portefølje».
«Dette er en aksje som mange har tapt store penger på gjennom årene.
......men nå indikerer analysen at timingen for kjøp er dårlig», sa analytiker Geir Linløkken til Finansavisen.
«Dette er en aksje som mange har tapt store penger på gjennom årene.
......men nå indikerer analysen at timingen for kjøp er dårlig», sa analytiker Geir Linløkken til Finansavisen.
Winter is Here
24.05.2023 kl 20:31
6367
Kor mange emisjoner har idex hatt siden børsnoteringen ?
Har de rekorden med tanke på antall emisjoner ?
Så mange emisjoner uten å levere lønnsomhet ?
Kor mange børsmeldinger har de generert som er bare luft ?
Har de rekorden med tanke på antall emisjoner ?
Så mange emisjoner uten å levere lønnsomhet ?
Kor mange børsmeldinger har de generert som er bare luft ?
Redigert 24.05.2023 kl 20:32
Du må logge inn for å svare
Pål stvg
24.05.2023 kl 20:38
6331
Ja det har tatt lang tid men det er ikke idex sin feil.Det er bankene som holder igjen. Men der ser jo virkelig ut som det er i ferd med å løsne nå.så har man tro på at sensor i kort er det nye så er idex ett kjempe kjøp. Det er ett enormt marked og kun en konkurrent per dags dato.
aklm
24.05.2023 kl 21:07
6186
Investtech, de med forskningssjefer på hode og skuldre.? Forskningssjef høres betryggende ut.
Sente
24.05.2023 kl 21:16
6140
Det logiske hadde nok vært å slå Idex konkurs etter mobil satsingen feilet.
Så starte opp et nytt selskap for satsing på kort.
Jeg vurderer Idex som et relativt nytt selskap med noe bagasje. :)
Så starte opp et nytt selskap for satsing på kort.
Jeg vurderer Idex som et relativt nytt selskap med noe bagasje. :)
Sente
24.05.2023 kl 21:17
6116
Vel, historien viser at Idex vanligvis går opp rett etter emisjon, så vi får se om Investtech kom med en god anbefaling eller ikke.
Sente
24.05.2023 kl 21:21
6085
Takk.
At du mener jeg har slagkraft til å påvirke verdien til et selskap til 1 milliard kroner med et par innlegg på et forum tar jeg til meg.
Og at dine egne innlegg har så lite effekt på kursen bør du også ta lærdom fra.
At du mener jeg har slagkraft til å påvirke verdien til et selskap til 1 milliard kroner med et par innlegg på et forum tar jeg til meg.
Og at dine egne innlegg har så lite effekt på kursen bør du også ta lærdom fra.
ibyx
24.05.2023 kl 21:23
6064
Luft eller ei. Meldingene har i det minste generert børshandel...
Under litt tvil poster jeg dette oppsettet (utdrag) fra en av IDEX kritikere på Shareville. Går ikke god for at alt er riktig selvsagt, men det ser sånn passe tilforlatelig ut da.
Dette som et delsvar på dette med børsmeldingene. Andre får evt supplere med 2022/2023. Dette er kun årene 2019-2021.
2019
1) IDEX Biometrics and Quest Payment Systems sign agreement to deliver biometric smart cards in Australasia
2) IDEX Biometrics and DWA collaborate to bring biometric secure access smart cards to market
3) IDEX begins deliveries of its dual-interface sensor to world class electronics manufacturer(0)
4) IDEX Biometrics signs on-card enrollment patent license agreement with Chutian Dragon
5) IDEX Biometrics’ remote enroll solution outperforms requirements for global payment certification
6) IDEX Biometrics and Feitian to offer cost-effective, supply chain solution for biometric smart card manufacturers
7) IDEX partners with Silone Cardtech to accelerate high volume production of biometric smart cards
8) IDEX Biometrics’ dual-interface technology validated by independent labs to meet multiple global payment schemes’ certification
9) Biometric smart card production, with IDEX dual-interface sensor, reaches low-cost, mass production milestone
10) Major Global Payment Scheme in Asia Certifying Biometric Card with IDEX sensor
11) IDEX Biometrics and TMC collaborate to accelerate biometric smart card adoption
12) IDEX partners with Sian to accelerate high volume production of biometric smart cards
13) IDEX Biometric sensors enabling greater financial inclusion in Mexico
14) Leading Asian payment scheme demonstrates biometric cards featuring IDEX dual-interface fingerprint sensor
15) IDEX Biometrics cements leadership position in biometric cards with grant of foundational patents for on-card enrollment
16) IDEX signs agreement with leading provider of global financial news and IT services to supply next generation secure fingerprint system
17) IDEX and Chutian Dragon collaborates with points of sales terminal provider PAX to accelerate biometric smart card adoption in Asia
18) IDEX ASA: IDEX expects to enter into agreement with a major global IT provider to supply high volumes of next generation secure F
19) XH Smart Tech showcasing dual-interface biometric card with IDEX sensor at Mobile World Congress in Barcelona
20) IDEX Biometrics and Goldpac partners to introduce dual-interface biometric smart cards
IDEX omsætning var 1.396.000 NKR altså intet salg Jamen hvad så med 2020 ?
1) IDEX Biometrics and Partner Goldpac Achieve China Union Pay Certification for Dual Interface Biometric Payment Cardsxx
2) IDEX Biometrics Receives Additional Production Order for TrustedBio™ Sensors from a Tier 1 Card Manufacturer(0)
3) IDEX Biometrics and Fudan Microelectronics Collaborate on Biometric Card Systems Integrationxx
4) IDEX Biometrics Receives Volume Order for IDX3205 Sensors from Hengbao(0)xx
5) IDEX Biometrics Receives Volume Production Order for TrustedBio™ Sensors from Ubivelox(0)xx
6) IDEX Biometrics Receives Production Order from Zwipe as the Roll-Out of Biometric Cards Accelerates(0)xx
7) IDEX Biometrics Receives Volume Production Orders for Current and Next Generation Fingerprint Sensors from Dongwoon Anatech(0)xx
8) Ubivelox, the Global Smart Card and Software Manufacturer, selects IDEX Biometrics TrustedBio™ Fingerprint Sensors and Biometric Soxx
9) IDEX Biometrics Receives Volume Production Order for TrustedBio Sensors from Tier 1 Card Manufacturer for Delivery in 2020(0)xx
10) IDEX Biometrics first shipment of TrustedBio: Raises the bar further for Cost, Performance and Security
11) China UnionPay awards Letter of Approval to biometric card showcasing IDEX Biometrics’ technology
12) IDEX Biometrics and Tongxin Microelectronics collaboration results in China UnionPay certificationxx
13) IDEX Biometrics and Zwipe collaborate on Zwipe Pay One Platform
14) IDEX Biometrics’ technology certified by an additional global payment network
15) IDEMIA, Zwipe and IDEX Biometrics achieve key milestone towards next generation biometric card platform
16) IDEX Biometrics and partner FEITIAN Technologies achieve industry’s first certification for China UnionPay dual-interface biometric payment card requirements
17) IDEX Biometrics’ TrustedBioTM Sensor Selected by a Leading Global Tier 1 Smartcard Manufacturer for Biometric Payment Cards
18) IDEX Biometrics set to drive down cost of biometric smartcards with new TrustedBio™ family of products and solutions
19) IDEX Biometrics Has Received its First Production Orders of a Multimillion-dollar Commitment from a Leading Global Provider (0)
20) IDEX Biometrics is the First Biometric Sensor Company to Achieve EMVCo Certification 29.01.2020
IDEX omsætning var 1.013.000 $ men stadig næsten intet salg Jamen så må 2021 da give overskud
1) IDEX Biometrics expands partnership in cyber security authenticationxx
2) IDEX Biometrics Announces a New Strategic Partnership with leading Global Smart Card Manufacturerxx
3) IDEX Biometrics enables turnkey solution for Biometric Smart Cards with partners jNet and Infineon Technologiesxx
4) Hengbao Dual-Use Smart Card Secured by IDEX Biometrics Approved for Certification by China UnionPay
5) IDEX Biometrics Receives High Volume Order for Mass Production of TrustedBio Fingerprint Sensors(0)
6) Mastercard Certifies Biometric Smart Card Secured by IDEX Biometrics
7) VISA Certifies Biometric Payment Card Secured by IDEX Biometrics TrustedBio Solution
8) IDEX Biometrics Receives an Order for its TrustedBio™ Sensor(0)
9) IDEX Biometrics announces TrustedBio™ Max
10) IDEX Biometrics ships latest reference platform for biometric smart cards to global smart card manufacturer
11) Infineon and IDEX Biometrics announce a platform for biometric smart cards with superior performance and scalable, cost-effectiveXX
12) IDEX Biometrics Enabling Smart Cards to be Issued by China Construction Bank(0)xx
13) IDEX Biometrics Receives Additional Production Order for TrustedBio™ Sensors(0)
14) IDEX Biometrics & Chutian Dragon to Jointly Develop Advanced Digital Currency Solutionsxx
15) First Biometric Payment Cards Based on IDEX Biometrics’ TrustedBio Introduced by IDEMIA (0)xx
16) IDEX Biometrics Shipping TrustedBio™ Fingerprint Sensors from its Mass Production Supply Chain
17) IDEX Biometrics Selected as Strategic Technology Partner for Goldpac’s DC/EP Hardware Wallet Initiativexx
18) IDEX Biometrics Further Strengthens its Supply Chain by Partnering with MFLEXxx
19) IDEX Biometrics’ Sensors Featured in Digital RMB Hardware Wallet Trials by the Postal Savings Bank of China(0)xx
20) China UnionPay Awards Second LOA to Biometric Payment Card Featuring IDEX Biometrics’ Fingerprint Sensor & Biometric Technology
21) IDEX Biometrics Expands Landmark Partnership with Global Payment Solutions Provider to Include Joint Marketing and Salesxx
22) IDEX Biometrics & Tongxin Microelectronics Collaboration Achieves Second China UnionPay Certification
23) IDEX Biometrics Expands its Strategic Partnerships by Adding Another Global Payment Networkxx
....
Som en annen måte å spørre på om antall emisjoner de har hatt, hvor mye penger har de brukt på å komme der de er idag?
Det er gjerne ikke så interessant. Spist er spist. :-)
Under litt tvil poster jeg dette oppsettet (utdrag) fra en av IDEX kritikere på Shareville. Går ikke god for at alt er riktig selvsagt, men det ser sånn passe tilforlatelig ut da.
Dette som et delsvar på dette med børsmeldingene. Andre får evt supplere med 2022/2023. Dette er kun årene 2019-2021.
2019
1) IDEX Biometrics and Quest Payment Systems sign agreement to deliver biometric smart cards in Australasia
2) IDEX Biometrics and DWA collaborate to bring biometric secure access smart cards to market
3) IDEX begins deliveries of its dual-interface sensor to world class electronics manufacturer(0)
4) IDEX Biometrics signs on-card enrollment patent license agreement with Chutian Dragon
5) IDEX Biometrics’ remote enroll solution outperforms requirements for global payment certification
6) IDEX Biometrics and Feitian to offer cost-effective, supply chain solution for biometric smart card manufacturers
7) IDEX partners with Silone Cardtech to accelerate high volume production of biometric smart cards
8) IDEX Biometrics’ dual-interface technology validated by independent labs to meet multiple global payment schemes’ certification
9) Biometric smart card production, with IDEX dual-interface sensor, reaches low-cost, mass production milestone
10) Major Global Payment Scheme in Asia Certifying Biometric Card with IDEX sensor
11) IDEX Biometrics and TMC collaborate to accelerate biometric smart card adoption
12) IDEX partners with Sian to accelerate high volume production of biometric smart cards
13) IDEX Biometric sensors enabling greater financial inclusion in Mexico
14) Leading Asian payment scheme demonstrates biometric cards featuring IDEX dual-interface fingerprint sensor
15) IDEX Biometrics cements leadership position in biometric cards with grant of foundational patents for on-card enrollment
16) IDEX signs agreement with leading provider of global financial news and IT services to supply next generation secure fingerprint system
17) IDEX and Chutian Dragon collaborates with points of sales terminal provider PAX to accelerate biometric smart card adoption in Asia
18) IDEX ASA: IDEX expects to enter into agreement with a major global IT provider to supply high volumes of next generation secure F
19) XH Smart Tech showcasing dual-interface biometric card with IDEX sensor at Mobile World Congress in Barcelona
20) IDEX Biometrics and Goldpac partners to introduce dual-interface biometric smart cards
IDEX omsætning var 1.396.000 NKR altså intet salg Jamen hvad så med 2020 ?
1) IDEX Biometrics and Partner Goldpac Achieve China Union Pay Certification for Dual Interface Biometric Payment Cardsxx
2) IDEX Biometrics Receives Additional Production Order for TrustedBio™ Sensors from a Tier 1 Card Manufacturer(0)
3) IDEX Biometrics and Fudan Microelectronics Collaborate on Biometric Card Systems Integrationxx
4) IDEX Biometrics Receives Volume Order for IDX3205 Sensors from Hengbao(0)xx
5) IDEX Biometrics Receives Volume Production Order for TrustedBio™ Sensors from Ubivelox(0)xx
6) IDEX Biometrics Receives Production Order from Zwipe as the Roll-Out of Biometric Cards Accelerates(0)xx
7) IDEX Biometrics Receives Volume Production Orders for Current and Next Generation Fingerprint Sensors from Dongwoon Anatech(0)xx
8) Ubivelox, the Global Smart Card and Software Manufacturer, selects IDEX Biometrics TrustedBio™ Fingerprint Sensors and Biometric Soxx
9) IDEX Biometrics Receives Volume Production Order for TrustedBio Sensors from Tier 1 Card Manufacturer for Delivery in 2020(0)xx
10) IDEX Biometrics first shipment of TrustedBio: Raises the bar further for Cost, Performance and Security
11) China UnionPay awards Letter of Approval to biometric card showcasing IDEX Biometrics’ technology
12) IDEX Biometrics and Tongxin Microelectronics collaboration results in China UnionPay certificationxx
13) IDEX Biometrics and Zwipe collaborate on Zwipe Pay One Platform
14) IDEX Biometrics’ technology certified by an additional global payment network
15) IDEMIA, Zwipe and IDEX Biometrics achieve key milestone towards next generation biometric card platform
16) IDEX Biometrics and partner FEITIAN Technologies achieve industry’s first certification for China UnionPay dual-interface biometric payment card requirements
17) IDEX Biometrics’ TrustedBioTM Sensor Selected by a Leading Global Tier 1 Smartcard Manufacturer for Biometric Payment Cards
18) IDEX Biometrics set to drive down cost of biometric smartcards with new TrustedBio™ family of products and solutions
19) IDEX Biometrics Has Received its First Production Orders of a Multimillion-dollar Commitment from a Leading Global Provider (0)
20) IDEX Biometrics is the First Biometric Sensor Company to Achieve EMVCo Certification 29.01.2020
IDEX omsætning var 1.013.000 $ men stadig næsten intet salg Jamen så må 2021 da give overskud
1) IDEX Biometrics expands partnership in cyber security authenticationxx
2) IDEX Biometrics Announces a New Strategic Partnership with leading Global Smart Card Manufacturerxx
3) IDEX Biometrics enables turnkey solution for Biometric Smart Cards with partners jNet and Infineon Technologiesxx
4) Hengbao Dual-Use Smart Card Secured by IDEX Biometrics Approved for Certification by China UnionPay
5) IDEX Biometrics Receives High Volume Order for Mass Production of TrustedBio Fingerprint Sensors(0)
6) Mastercard Certifies Biometric Smart Card Secured by IDEX Biometrics
7) VISA Certifies Biometric Payment Card Secured by IDEX Biometrics TrustedBio Solution
8) IDEX Biometrics Receives an Order for its TrustedBio™ Sensor(0)
9) IDEX Biometrics announces TrustedBio™ Max
10) IDEX Biometrics ships latest reference platform for biometric smart cards to global smart card manufacturer
11) Infineon and IDEX Biometrics announce a platform for biometric smart cards with superior performance and scalable, cost-effectiveXX
12) IDEX Biometrics Enabling Smart Cards to be Issued by China Construction Bank(0)xx
13) IDEX Biometrics Receives Additional Production Order for TrustedBio™ Sensors(0)
14) IDEX Biometrics & Chutian Dragon to Jointly Develop Advanced Digital Currency Solutionsxx
15) First Biometric Payment Cards Based on IDEX Biometrics’ TrustedBio Introduced by IDEMIA (0)xx
16) IDEX Biometrics Shipping TrustedBio™ Fingerprint Sensors from its Mass Production Supply Chain
17) IDEX Biometrics Selected as Strategic Technology Partner for Goldpac’s DC/EP Hardware Wallet Initiativexx
18) IDEX Biometrics Further Strengthens its Supply Chain by Partnering with MFLEXxx
19) IDEX Biometrics’ Sensors Featured in Digital RMB Hardware Wallet Trials by the Postal Savings Bank of China(0)xx
20) China UnionPay Awards Second LOA to Biometric Payment Card Featuring IDEX Biometrics’ Fingerprint Sensor & Biometric Technology
21) IDEX Biometrics Expands Landmark Partnership with Global Payment Solutions Provider to Include Joint Marketing and Salesxx
22) IDEX Biometrics & Tongxin Microelectronics Collaboration Achieves Second China UnionPay Certification
23) IDEX Biometrics Expands its Strategic Partnerships by Adding Another Global Payment Networkxx
....
Som en annen måte å spørre på om antall emisjoner de har hatt, hvor mye penger har de brukt på å komme der de er idag?
Det er gjerne ikke så interessant. Spist er spist. :-)
Sashaa
24.05.2023 kl 21:35
5980
Til å begynne med var jeg skeptisk til deg sente ,. Jeg var i Idex mindre enn 1,5 år . jeg i senere uker fått mer respekt for dine ord. Spendt på hva kursen blir imorgen, kan hende men ikke sikker min beholding faller i verdi 2-300k hvis kursen faller betydelig, men det gjør meg ikke noe med tanke på jeg har nylig hatt en realisert gevinst på over 1,4 mill. Fortsett å del dine meninger med oss.
Montesa
24.05.2023 kl 21:50
5900
Hvor ligger fabrikken til Idex egentlig? Og hvor mange kort kan de produsere løpet av et år? Tenker på når alle avtalene blir satt igang om de faktisk klare å levere alt?
elnomi
24.05.2023 kl 21:51
5889
Nå har en hatt 3 nylige eksempler på kriseemisjoner, BGBIO, nom og Archer. Hva skjer i dette emisjonsselskspet?
Winter is Here
24.05.2023 kl 21:54
5869
Jeg tror det er TSMC som lager sensorer, Idex driver med utvikling og design. Det er viktig at de planlegger litt, da TSMC har nok å gjøre det kan ta tid fra ordre blir lagt inn til sensorer er produsert.
Redigert 24.05.2023 kl 21:56
Du må logge inn for å svare
poki
24.05.2023 kl 22:18
5760
Jag tror det kommer en stor beställning från antingen från Indien eller Turkiet / US och iDEX behöver sensor beställning och 💰
Zwipe kommer med ny beställning snart kan jag tänka mig.
Zwipe kommer med ny beställning snart kan jag tänka mig.
Sashaa
24.05.2023 kl 22:33
5681
På sikt 2-6 måneder er sikkert kursen er over 2,5-3 Nok, det er det som er grunnlaget for jeg vil kjøpe alt under .
Sente
24.05.2023 kl 22:33
5678
Idex er "Fab-less", så de har ingen fabrikk. Winter er inne på noe med TSMC, for der blir ASIC laget.
I følge årsrapporten:
We currently rely on Taiwan Semiconductor Manufacturing Company, Limited (“TSMC”), the leading producer of semiconductor wafers, for production of our proprietary application specific integrated circuit (“ASIC”) designs. We also rely on a limited number of providers of assembly and test services, including Amkor Technology, Inc. and Silicon Precision Industries Limited (a unit of ASE Technology Holding Co., Ltd.), both of which are leaders in outsourced semiconductor assembly and test services
Sensor lages i to deler, Polymer "overflaten" og ASIC. disse monteres sammen og testes.
I følge årsrapporten:
We currently rely on Taiwan Semiconductor Manufacturing Company, Limited (“TSMC”), the leading producer of semiconductor wafers, for production of our proprietary application specific integrated circuit (“ASIC”) designs. We also rely on a limited number of providers of assembly and test services, including Amkor Technology, Inc. and Silicon Precision Industries Limited (a unit of ASE Technology Holding Co., Ltd.), both of which are leaders in outsourced semiconductor assembly and test services
Sensor lages i to deler, Polymer "overflaten" og ASIC. disse monteres sammen og testes.
Sente
24.05.2023 kl 22:35
5659
Takk for det og gratulere med gevinst. Jeg vil alltid anbefale folk å ta gevinst om de er fornøyd👍
tuja
24.05.2023 kl 23:04
5527
Ryktes om att emiprisen blir 85 øre. Ikke lenge før vi ser om dert stemmer. Det er i såfall sterkt av Idex.
Billyjojimbob
25.05.2023 kl 03:59
5341
Clay Allison
25.05.2023 kl 06:21
5274
Nå fikk du beklagelse og gratulasjon og din reaksjon er å sparke tilbake. du burde ta et crash kurs i möte og tale teknikk. Kanskje litt mer god gammaldags folkeskikk på flere av debutantene kunne värt en god ide.
Så får vi håpe på en god dag nå, så lykke til folket.
Så får vi håpe på en god dag nå, så lykke til folket.
Sente
25.05.2023 kl 06:58
5176
147 millioner aksjer på 0,85 kr, totalt 125M kroner.
Oslo, 24 May 2023. Reference is made to the press release from IDEX Biometrics ASA ("IDEX" or the "Company") published earlier today, 24 May 2023, regarding a contemplated private placement to raise gross proceeds of approximately NOK 100-150 million (the "Private Placement").
The Private Placement has been successfully placed and will raise gross proceeds to the Company of NOK 125 million, through the allocation of 147,058,824 new shares (the "Offer Shares") at a price of NOK 0.85 per Offer Share (the "Offer Price").
The Company intends to use the net proceeds from the Private Placement to accelerate the Company’s product commercialization and for working capital and general corporate purposes.
The Private Placement is divided into two tranches. Tranche 1 consists of 116,897,492 Offer Shares (representing approximately 10% of the outstanding shares in the Company) ("Tranche 1" and the "Tranche 1 Offer Shares"). Tranche 2 consists of 30,161,332 Offer Shares ("Tranche 2" and the "Tranche 2 Offer Shares"). Completion of Tranche 2 will be subject to approval by an extraordinary general meeting of the Company expected to be held on or about 16 June 2023 (the "EGM").
Notification of allocation and settlement instructions for Tranche 1 and Tranche 2 (conditional allocation for Tranche 2) will be communicated to investors on 25 May 2023.
Both Tranche 1 and Tranche 2 will be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement entered into between the Company, the Managers (as defined below) and certain existing shareholders (the "Share Lending Agreement"). The share loan in Tranche 1 will be settled with 116,897,492 new shares in the Company to be resolved issued by the Company's board of directors (the "Board") pursuant to an authorisation granted by the Company’s annual general meeting held on 23 May 2023. The share loan in Tranche 2 will be settled with new shares in the Company expected to be issued following, and subject to, approval by the EGM. The new shares to be redelivered to the lenders under the Share Lending Agreement will, to the extent required, be delivered on a separate and non-tradable ISIN, pending publication by the Company of a listing prospectus approved by the Norwegian Financial Supervisory Authority.
Settlement of the Tranche 1 Offer Shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. The Tranche 1 Offer Shares will be tradeable from allocation.
Completion of Tranche 2 is subject to (i) completion of Tranche 1 and (ii) the approval by the EGM. Completion of Tranche 1 will not be conditional upon or otherwise affected by the completion of Tranche 2, and the applicants' acquisition of Tranche 1 Offer Shares will remain final and binding and cannot be revoked, cancelled or terminated by the respective applicants if Tranche 2, for whatever reason, is not completed. Investors being allocated shares in the Private Placement have undertaken to vote in favour of Tranche 2 at the EGM.
Settlement of the Tranche 2 Offer Shares is expected to take place on a delivery versus payment basis on or about 20 June 2023, subject to approval by the EGM.
Following completion of Tranche 1 of the Private Placement, the Company's share capital will be NOK 192,880,861.8, divided into 1,285,872,412 shares, each with a nominal value of NOK 0.15. Following completion of both Tranche 1 and Tranche 2 of the Private Placement, the Company will have 1,316,033,744 shares outstanding.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it has been in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the funding alternatives currently available to the Company. By structuring the equity raise as a private placement, the Company has been able to raise equity efficiently, with a 6.3 percent discount to the closing price on the Oslo Stock Exchange on 24 May 2023, and at a lower cost and with significantly lower risk than in a rights issue.
The Board has on this basis resolved not to conduct a subsequent repair offering directed towards shareholders who did not participate in the Private Placement.
This information in this stock exchange announcement is considered to be inside information pursuant to the EU Market Abuse Regulation and is published in accordance with section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Erling Svela, VP finance on 24 May 2023 at 23:55 CEST on behalf of the Company.
Oslo, 24 May 2023. Reference is made to the press release from IDEX Biometrics ASA ("IDEX" or the "Company") published earlier today, 24 May 2023, regarding a contemplated private placement to raise gross proceeds of approximately NOK 100-150 million (the "Private Placement").
The Private Placement has been successfully placed and will raise gross proceeds to the Company of NOK 125 million, through the allocation of 147,058,824 new shares (the "Offer Shares") at a price of NOK 0.85 per Offer Share (the "Offer Price").
The Company intends to use the net proceeds from the Private Placement to accelerate the Company’s product commercialization and for working capital and general corporate purposes.
The Private Placement is divided into two tranches. Tranche 1 consists of 116,897,492 Offer Shares (representing approximately 10% of the outstanding shares in the Company) ("Tranche 1" and the "Tranche 1 Offer Shares"). Tranche 2 consists of 30,161,332 Offer Shares ("Tranche 2" and the "Tranche 2 Offer Shares"). Completion of Tranche 2 will be subject to approval by an extraordinary general meeting of the Company expected to be held on or about 16 June 2023 (the "EGM").
Notification of allocation and settlement instructions for Tranche 1 and Tranche 2 (conditional allocation for Tranche 2) will be communicated to investors on 25 May 2023.
Both Tranche 1 and Tranche 2 will be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement entered into between the Company, the Managers (as defined below) and certain existing shareholders (the "Share Lending Agreement"). The share loan in Tranche 1 will be settled with 116,897,492 new shares in the Company to be resolved issued by the Company's board of directors (the "Board") pursuant to an authorisation granted by the Company’s annual general meeting held on 23 May 2023. The share loan in Tranche 2 will be settled with new shares in the Company expected to be issued following, and subject to, approval by the EGM. The new shares to be redelivered to the lenders under the Share Lending Agreement will, to the extent required, be delivered on a separate and non-tradable ISIN, pending publication by the Company of a listing prospectus approved by the Norwegian Financial Supervisory Authority.
Settlement of the Tranche 1 Offer Shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. The Tranche 1 Offer Shares will be tradeable from allocation.
Completion of Tranche 2 is subject to (i) completion of Tranche 1 and (ii) the approval by the EGM. Completion of Tranche 1 will not be conditional upon or otherwise affected by the completion of Tranche 2, and the applicants' acquisition of Tranche 1 Offer Shares will remain final and binding and cannot be revoked, cancelled or terminated by the respective applicants if Tranche 2, for whatever reason, is not completed. Investors being allocated shares in the Private Placement have undertaken to vote in favour of Tranche 2 at the EGM.
Settlement of the Tranche 2 Offer Shares is expected to take place on a delivery versus payment basis on or about 20 June 2023, subject to approval by the EGM.
Following completion of Tranche 1 of the Private Placement, the Company's share capital will be NOK 192,880,861.8, divided into 1,285,872,412 shares, each with a nominal value of NOK 0.15. Following completion of both Tranche 1 and Tranche 2 of the Private Placement, the Company will have 1,316,033,744 shares outstanding.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it has been in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the funding alternatives currently available to the Company. By structuring the equity raise as a private placement, the Company has been able to raise equity efficiently, with a 6.3 percent discount to the closing price on the Oslo Stock Exchange on 24 May 2023, and at a lower cost and with significantly lower risk than in a rights issue.
The Board has on this basis resolved not to conduct a subsequent repair offering directed towards shareholders who did not participate in the Private Placement.
This information in this stock exchange announcement is considered to be inside information pursuant to the EU Market Abuse Regulation and is published in accordance with section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Erling Svela, VP finance on 24 May 2023 at 23:55 CEST on behalf of the Company.
nima
25.05.2023 kl 07:33
5034
Emisjon , emisjon, emisjon, hvor lenge har de penger nå ? det kommer vel noen positive meldinger før neste emisjon.
Sente
25.05.2023 kl 07:50
4932
Vel, Q1 resultatet var minus 74 millioner kr.
De har penger ut året med mindre de starter å tjene mer. Som CEO har sagt de skal gjøre i løpet av Q4.
De har penger ut året med mindre de starter å tjene mer. Som CEO har sagt de skal gjøre i løpet av Q4.
4300dk
25.05.2023 kl 07:59
4878
Nogen der ved hvem der har købt de nye aktier ? Spændende tider vi går i møde nu 😁
kroif
25.05.2023 kl 08:07
4831
Det som fortsatt tror at ikke IDEX kommer til å bli en moneymaker i nær fremtid bør ta seg en bolle, er tikker det inn gode nyheter daglig
MeldingsID
591575
UtstederID
IDEX
Marked
Oslo Børs
Kategori
IKKE-INFORMASJONSPLIKTIGE PRESSEMELDINGER
Del melding
Del til Facebook
Del til Twitter
Del til Linkedin
IDEX Biometrics and SELP to scale biometric smart card deployment globally
Oslo, Norway, 25 May- IDEX Biometrics and SELP, a French card manufacturer and
personalization center with a global footprint, are entering an agreement to
scale the deployment of biometric smart cards, in response to growing demand for
secure and convenient payment and identification solutions.
With an annual card production of more than 350 million and servicing over 60
countries across Europe, Central America, Africa, the Middle East, and India,
SELP is uniquely positioned to drive the commercialization of biometric
technology across a wide range of sectors including payments, digital ID,
digital services, and retail.
"This agreement enables us to strengthen the ecosystem and meet the increasing
demand for seamless payment and identification experiences," said Bastien Blanc,
General Manager of SELP. "By working with IDEX Biometrics, we can offer the
highest-performing and cost-efficient biometric card solution to our customers."
"We are thrilled to partner with SELP to bring our solution to customers in new
markets," said Catharina Eklof, CCO of IDEX Biometrics. "With SELP's extensive
portfolio and expertise in the payments and identification markets, we are
confident that we will accelerate adoption of biometric payment technology at
scale."
For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=rkgcatcBoWPEMgWuMjJo7UeqmFaUP-
2q6NdVnf7hWAs1jVoHGnVyzdNlgXpm8DaLAGQ066AJ95NTspNt6j-
MMm91y4hkYP8oVC7ciqbdzHyxkRXEotoTYvjHybr0WJrP)Tel: + 47 918 00186
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a global technology leader
in fingerprint biometrics, offering authentication solutions across payments,
access control, and digital identity. Our solutions bring convenience, security,
peace of mind and seamless user experiences to the world. Built on patented and
proprietary sensor technologies, integrated circuit designs, and software, our
biometric solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=BH-L2BSyLxkXYAc-Va1tCwihBe7E8h6-
7E68b-g2VDjyYnc2Hp4_Z1fD9Zhy5zgCva4Dek2W4Jlz0YeUo19_R5v5ld5Dc1jUvA0tRRsS-lQ=).
MeldingsID
591575
UtstederID
IDEX
Marked
Oslo Børs
Kategori
IKKE-INFORMASJONSPLIKTIGE PRESSEMELDINGER
Del melding
Del til Facebook
Del til Twitter
Del til Linkedin
IDEX Biometrics and SELP to scale biometric smart card deployment globally
Oslo, Norway, 25 May- IDEX Biometrics and SELP, a French card manufacturer and
personalization center with a global footprint, are entering an agreement to
scale the deployment of biometric smart cards, in response to growing demand for
secure and convenient payment and identification solutions.
With an annual card production of more than 350 million and servicing over 60
countries across Europe, Central America, Africa, the Middle East, and India,
SELP is uniquely positioned to drive the commercialization of biometric
technology across a wide range of sectors including payments, digital ID,
digital services, and retail.
"This agreement enables us to strengthen the ecosystem and meet the increasing
demand for seamless payment and identification experiences," said Bastien Blanc,
General Manager of SELP. "By working with IDEX Biometrics, we can offer the
highest-performing and cost-efficient biometric card solution to our customers."
"We are thrilled to partner with SELP to bring our solution to customers in new
markets," said Catharina Eklof, CCO of IDEX Biometrics. "With SELP's extensive
portfolio and expertise in the payments and identification markets, we are
confident that we will accelerate adoption of biometric payment technology at
scale."
For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=rkgcatcBoWPEMgWuMjJo7UeqmFaUP-
2q6NdVnf7hWAs1jVoHGnVyzdNlgXpm8DaLAGQ066AJ95NTspNt6j-
MMm91y4hkYP8oVC7ciqbdzHyxkRXEotoTYvjHybr0WJrP)Tel: + 47 918 00186
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a global technology leader
in fingerprint biometrics, offering authentication solutions across payments,
access control, and digital identity. Our solutions bring convenience, security,
peace of mind and seamless user experiences to the world. Built on patented and
proprietary sensor technologies, integrated circuit designs, and software, our
biometric solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=BH-L2BSyLxkXYAc-Va1tCwihBe7E8h6-
7E68b-g2VDjyYnc2Hp4_Z1fD9Zhy5zgCva4Dek2W4Jlz0YeUo19_R5v5ld5Dc1jUvA0tRRsS-lQ=).
vulkan
25.05.2023 kl 08:50
4658
Syk skuffende at de ikke klarte å sette kursen lik forrige emisjon, nå som IDEX åpenbart er nærmere kommersialisering....
Redigert 25.05.2023 kl 08:52
Du må logge inn for å svare
ibyx
25.05.2023 kl 09:17
4568
Tror vi kan få en liten repeat av handelen etter forrige emisjon? Først en god del knuffing og 5-10% fall med ditto stoploss. Så kommer oppgangen ettergert styrket short og gevinstsikring?
ibyx
25.05.2023 kl 12:05
4333
Omsetningen 17. november første dag etter forrige emisjon var ca 19MNOK og kursen endte ca 5% under emikurs. Så begynte oppgangen...
Kan jo ikke bli helt blåkopi denne gang? Ser allerede at salgsviljen er mindre, men i rødt da. (Eller det kjøpes mer tettere på emikurs for å si det slik)
Etter snart halv dag er omsetningen nå 10,5 MNOK. Volummessig er vi altså helt på linje.
Ikke uvesentlig tenker jeg, for dette handler om kvantiteter og spekulasjon med disse, hvor emikurs selvsagt er en faktor (også forrige)?
Uforutsette ting kan selvsagt skje. Begge veier! For selv de toneangivende her har ikke "full kontroll" med kursen?
Kan jo ikke bli helt blåkopi denne gang? Ser allerede at salgsviljen er mindre, men i rødt da. (Eller det kjøpes mer tettere på emikurs for å si det slik)
Etter snart halv dag er omsetningen nå 10,5 MNOK. Volummessig er vi altså helt på linje.
Ikke uvesentlig tenker jeg, for dette handler om kvantiteter og spekulasjon med disse, hvor emikurs selvsagt er en faktor (også forrige)?
Uforutsette ting kan selvsagt skje. Begge veier! For selv de toneangivende her har ikke "full kontroll" med kursen?
Redigert 25.05.2023 kl 12:12
Du må logge inn for å svare
-
«
- 1
- 2 »